1、血液透析用血管通路的建立及并发症处理血液透析用血管通路的背景介绍尿毒症患者的全球增长态势Lancet. 2015; 385: 1975-1982中国血液透析患者逐年增加Clin Nephrol. 2010; 74: s20-s22卫生部质控中心数据中华肾脏病杂志 . 2001; 17: 77-78预计我国尿毒症患病率将快速增长北京血液净化质控中心年度报告 2013USRDS ADR 2013各种血管通路的花费 -加拿大资料Seminars in Dialysis. 2009;22:539544欧美日患者死亡率差异 DOPPS 1 (1996-2001)Survival (%) Unadjust
2、ed Adjusted for demographics and comorbidities*Years YearsEurope (ref)Japan (HR = 0.3)US(HR=1.8)Europe (ref)Japan (HR = 0.3)US(HR=1.3)* N=16,720 patients, adjusted accounting for facility clustering, adjusted model containing smoking status, vintage, age, BMI, sex, and 14 comorbid conditions by adjusting all curves to mean values Ref. group updated, Goodkin et al. JASN (2003)MHD死亡率：北京 vs. USRDSNephrol Dial Transplant (2011) 26: 33193324各国血管通路使用习惯相差很多Am J Kidney Dis. 2015;65(6):905-915血液透析用血管通路的类型选择
